<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mediators Inflamm</journal-id><journal-id journal-id-type="iso-abbrev">Mediators Inflamm</journal-id><journal-id journal-id-type="publisher-id">MI</journal-id><journal-title-group><journal-title>Mediators of Inflammation</journal-title></journal-title-group><issn pub-type="ppub">0962-9351</issn><issn pub-type="epub">1466-1861</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23690659</article-id><article-id pub-id-type="pmc">3649701</article-id><article-id pub-id-type="doi">10.1155/2013/260925</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Role of Neuroinflammation in Adult Neurogenesis and Alzheimer Disease: Therapeutic Approaches</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">0000-0003-4145-9822</contrib-id><name><surname>Fuster-Matanzo</surname><given-names>Almudena</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Llorens-Mart&#x000ed;n</surname><given-names>Mar&#x000ed;a</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>F&#x000e9;lix</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Avila</surname><given-names>Jes&#x000fa;s</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Molecular Neurobiology, Centro de Biolog&#x000ed;a Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain</aff><aff id="I2"><sup>2</sup>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), 28031 Madrid, Spain</aff><author-notes><corresp id="cor1">*Jes&#x000fa;s Avila: <email>javila@cbm.uam.es</email></corresp><fn fn-type="other"><p>Academic Editor: Diego Gomez-Nicola</p></fn></author-notes><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>3</day><month>4</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>260925</elocation-id><history><date date-type="received"><day>29</day><month>11</month><year>2012</year></date><date date-type="accepted"><day>12</day><month>3</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Almudena Fuster-Matanzo et al.</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Neuroinflammation, a specialized immune response that takes place in the central nervous system, has been linked to neurodegenerative diseases, and specially, it has been considered as a hallmark of Alzheimer disease, the most common cause of dementia in the elderly nowadays. Furthermore, neuroinflammation has been demonstrated to affect important processes in the brain, such as the formation of new neurons, commonly known as adult neurogenesis. For this, many therapeutic approaches have been developed in order to avoid or mitigate the deleterious effects caused by the chronic activation of the immune response. Considering this, in this paper we revise the relationships between neuroinflammation, Alzheimer disease, and adult neurogenesis, as well as the current therapeutic approaches that have been developed in the field.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>The inflammatory response is an early, specialized immune reaction to tissue damage or pathogen invasion. In the central nervous system (CNS), this process is known as neuroinflammation and is characterized by the activation of the microglia and astrocytes population [<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B3">3</xref>], the increase in concentration of different cytokines, and chemokines and, under certain conditions, the disruption of the blood brain barrier and the subsequent invasion of cells from the hematopoietic system to the injury site [<xref ref-type="bibr" rid="B4">4</xref>]. Thus, the burden of protecting CNS from injury falls on a specific group of cells: microglia, astrocytes, and mast cells. Mast cells can be found within the brain and their functions include the attractant and activation of other immune cells by secreting proinflammatory cytokines, and chemoattractants [<xref ref-type="bibr" rid="B5">5</xref>]. Astrocytes also contribute to the immune response by liberating both pro- and anti-inflammatory cytokines, chemokines and complement components [<xref ref-type="bibr" rid="B6">6</xref>]. Finally, microglia (CNS-resident macrophages) represent the main effector cells of the immune system in the CNS. Under physiological conditions, they stay as a quiescent population. In response to an infection or injury, they activate acquiring a reactive inflammatory phenotype characterized by an increased proliferation, morphological changes, and the release of several inflammatory molecules such as cytokines, reactive oxygen species, and nitric oxide [<xref ref-type="bibr" rid="B7">7</xref>]. </p><p>Some aspects of the neuroinflammatory response result beneficial for CNS outcomes. Among these benefits, neuroprotection phenomena, the maintenance of neurogenesis as a mechanism of brain repair, the mobilization of neural precursors for repair, remyelination, and even axonal regeneration are included [<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. However, neuroinflammation can be harmful too, leading to neuronal damage. Benefits and detriments balance depends largely on the magnitude of the immune response. In this sense, it is important to distinguish between the two types of responses in which inflammatory mechanism has traditionally been classified: acute and chronic inflammation. The first one comprises the immediate and early response to an injurious agent and is basically a defensive response that paves the way for repair of the damaged site being typically short-lived and unlikely to be detrimental to long-term neuronal survival [<xref ref-type="bibr" rid="B10">10</xref>]. The chronic response occurs when the harmful stimulus persists over time and contrary to the acute form, it is a long-standing and often self-perpetuating neuroinflammatory response which in the end, results in detrimental consequences for neurons [<xref ref-type="bibr" rid="B11">11</xref>]. Both acute and chronic responses have been related with neurodegenerative disorders. Thus, stroke and injury would associate with acute neuroinflammation while diseases such as multiple sclerosis or Alzheimer disease (AD) would be associated with the chronic form of the response. In this scenario, another important process commonly related with neurodegeneration and neuroinflammation emerges; the formation of new neurons in the adulthood or adult neurogenesis. </p><p>Adult neurogenesis occurs in mammals principally in two brain regions: the subventricular zone (SVZ) and the subgranular zone (SGZ) of the hippocampus. The neuronal precursor cells (NPCs) that exist in both areas are a subset of astrocytes that give rise to intermediate progenitors which migrate and differentiate into new neurons of the hippocampus (in SGZ neurogenesis) or the olfactory bulb (in SVZ neurogenesis) [<xref ref-type="bibr" rid="B12">12</xref>]. Adult neurogenesis has been found to be altered in several neurodegenerative disorders such as Parkinson's disease, Huntington's disease, and AD (for a review, see [<xref ref-type="bibr" rid="B13">13</xref>]). On the other hand, neuroinflammation is a common feature of all these pathologies and, as it will be commented in detail later, it has also a relevant influence on adult neurogenesis. </p><p>Due to the interconnection among these processes, it is important to consider them as a whole, taking into account that alterations affecting any of them would probably have consequences on the two others. </p><p>In this review, we will summarize the role of neuroinflammation in both adult neurogenesis and Alzheimer disease. Related to this pathology, we will finally revise the recent advances concerning therapeutic approaches with neuroinflammatory mechanisms as a main target. </p></sec><sec id="sec2"><title>2. Neuroinflammation and Adult Neurogenesis</title><p>It has been widely demonstrated that neuroinflammation affects adult neurogenesis having both detrimental and beneficial consequences which can result in enhancement and/or inhibition of the process. The final result depends largely on how microglia, macrophages, and/or astrocytes are activated and the duration of the inflammation [<xref ref-type="bibr" rid="B14">14</xref>]. Furthermore, the balance between the benefits and the detriments will have a profound impact on the efficiency of brain repair [<xref ref-type="bibr" rid="B15">15</xref>], which is of great importance in the context of the neurodegenerative disorders.</p><p>It is known that microglia, as the first immunological barrier against pathogens and environmental insults [<xref ref-type="bibr" rid="B16">16</xref>], exert the aforementioned dual effects on adult neurogenesis, resulting in pro or antineutogenic outcomes.</p><sec id="sec2.1"><title>2.1. Proneurogenic Effects</title><p>An important study performed by Sierra and colleagues demonstrated that resting microglia play a crucial role in regulating the balance of newborn neurons in the hippocampus thanks to their phagocytic capacities [<xref ref-type="bibr" rid="B17">17</xref>]. Of the thousands of new cells born in the SGZ of the dentate gyrus, only a part of them differentiate and maturate into fully mature neurons. At least half of these cells die, probably through apoptosis, within the first few days to weeks after they are born [<xref ref-type="bibr" rid="B18">18</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>]. Sierra et al. [<xref ref-type="bibr" rid="B17">17</xref>] provided data that attributed to microglia the function of removing those apoptotic new cells by phagocytosis. Furthermore, they importantly proved that this action did not require the activation of the microglial population. Recently, it has been reported that not only microglia are essential for adult neurogenesis but their functions and activity are importantly regulated by neuronal progenitor cells too. Thus, NPC-derived secreted factors are capable of modulating microglia activation, proliferation, and phagocytosis [<xref ref-type="bibr" rid="B22">22</xref>]. This crosstalk persists during neuron lifetime, since adult neurons are demonstrated to regulate microglia activation by constitutively expression of several neuroimmunoregulatory proteins such as CD200, CX<sub>3</sub>CL1 (or fractalkine), CD47, CD55, or HMGB1 (for a review see [<xref ref-type="bibr" rid="B23">23</xref>]). </p><p>Further evidence of the proneurogenic effects of unchallenged microglia comes from the work of Walton and colleagues. By <italic>in vitro</italic> studies they showed that this population releases factors that rescue neuroblasts and instruct neuronal cell differentiation [<xref ref-type="bibr" rid="B24">24</xref>]. </p><p>However, not only resting microglia exert benefits on adult neurogenesis. The acquisition of an active phenotype, under certain conditions, can be beneficial too [<xref ref-type="bibr" rid="B16">16</xref>], thanks to the liberation of anti-inflammatory cytokines with a broad range of actions on neurogenesis. Among these, we can highlight interleukin-4 and -10 (IL-4, IL-10) and transforming growth factor-beta (TGF-<italic>&#x003b2;</italic>). It is also important to keep in mind that cytokines classically considered as proinflammatory, such as interleukin-6 (IL-6), interleukin 1-<italic>&#x003b2;</italic> (IL-1<italic>&#x003b2;</italic>), and tumor necrosis factor-<italic>&#x003b1;</italic> (TNF-<italic>&#x003b1;</italic>) can be involved in the creation of a permissive environment for neurorepair too [<xref ref-type="bibr" rid="B25">25</xref>], as several studies have demonstrated (see <xref ref-type="table" rid="tab1">Table 1</xref>).</p><p>Finally, not only cytokines derived from microglia can positively regulate neurogenesis. Other factors produced by immune system cells which are involved in the neuroinflammatory response have been shown to have certain influence. This is the case for granulocyte-macrophage colony stimulating factor (GM-CSF) [<xref ref-type="bibr" rid="B26">26</xref>] and the granulocyte-colony stimulating factor (G-CSF), with remarkable effects on the differentiation of NSC <italic>in vitro</italic> [<xref ref-type="bibr" rid="B27">27</xref>] (<xref ref-type="table" rid="tab1">Table 1</xref>). </p></sec><sec id="sec2.2"><title>2.2. Antineurogenic Effects</title><p>Neuroinflammation, although beneficial as a physiological response to maintain brain homeostasis, can have detrimental effects especially when it turns out to be a chronic response. Activated miroglia release proinflammatory cytokines which have been shown to affect largely neurogenesis. The aforementioned IL-6, TNF-<italic>&#x003b1;</italic>, and IL-1<italic>&#x003b2;</italic> but also interleukin-1-alpha (IL-1<italic>&#x003b1;</italic>), interleukin-18 (IL-18) and interferon-<italic>&#x003b3;</italic> (IFN-<italic>&#x003b3;</italic>) have detrimental consequences for proliferation and/or differentiation of NSC (<xref ref-type="table" rid="tab1">Table 1</xref>). Among factors not released by microglia, CCL11 or eotaxin-1, a small chemokine known by its implication in allergic responses, has been recently linked to adult neurogenesis and ageing [<xref ref-type="bibr" rid="B28">28</xref>]. When administered systemically to young mice, eotaxin is able to impair neurogenesis producing as a consequence, learning and memory deficits [<xref ref-type="bibr" rid="B28">28</xref>]. Furthermore, it seems to affect directly the number and size of neurospheres formed from primary NPCs [<xref ref-type="bibr" rid="B28">28</xref>], suggesting that precursor cells probably have receptors capable of binding the cytokine.</p><p>Finally, it is especially noteworthy to keep in mind that most of the aforementioned factors are not only produced by microglia, but for astrocytes too, which contribute to the pathogenesis of neurodegenerative disorders as will be commented later. </p><p>The effects of the abovementioned cytokines on neurogenesis are summarized in <xref ref-type="table" rid="tab1">Table 1</xref>. </p></sec></sec><sec id="sec3"><title>3. Neuroinflammation and Alzheimer Disease</title><p>Neurodegenerative diseases are characterized by the progressive loss of neurons from specific regions of the CNS, which is believed to account for the cognitive and motor impairments suffered by patients with these neurodegenerative disorders. Importantly, inflammation is a process that has been closely related to the onset of many of these diseases, such as Amyotrophic Lateral Syndrome (ALS), Multiple Sclerosis (MS), Parkinsons Disease (PD) and Alzheimer Disease (AD) [<xref ref-type="bibr" rid="B29">29</xref>&#x02013;<xref ref-type="bibr" rid="B33">33</xref>]. Indeed, aberrant inflammatory responses are believed to play a role in the etiology of these disorders.</p><p>At present, AD is the most common cause of dementia in the elderly. It is estimated that 27 million people are affected worldwide [<xref ref-type="bibr" rid="B34">34</xref>] and this number is expected to triple by 2050 due to the increase of the population life expectancy [<xref ref-type="bibr" rid="B35">35</xref>]. AD is a neurodegenerative disorder which affects brain regions that control memory and cognitive functions, which implies that patients finally lose their memory and ability to learn, to reason, to communicate and to carry out daily activities [<xref ref-type="bibr" rid="B36">36</xref>]. There are two different types of Alzheimer Disease, familiar Alzheimer Disease (FAD) and Sporadic Alzheimer Disease (SAD), and the origin of the disease could be different in both familial and sporadic cases. In terms of FAD, mutations in three different genes (presenilin-1 PS-1, presenilin 2 PS-2 and amyloid precursor protein APP) are likely to promote the onset of the disease whereas for SAD, different risk factors might be involved. Nevertheless, downstream the initial causes of the disease some common factors may be involved [<xref ref-type="bibr" rid="B57">37</xref>]. At a molecular level, AD is characterized by the presence of two main hystopathological hallmarks: senile plaques (extracellular aggregates composed by amyloid peptide or A<italic>&#x003b2;</italic>) and neurofibrillary tangles (intracellular aggregates composed by hyperphosphorylated forms of tau protein). A<italic>&#x003b2;</italic> results from the cleavage of APP and, although it seems to have important developmental functions in cell differentiation and possibly in the establishment of synapses [<xref ref-type="bibr" rid="B58">38</xref>, <xref ref-type="bibr" rid="B59">39</xref>], its functions in adult brain still remain unclear. On the other hand, tau protein, the major component of neurofibrillary tangles, is a microtubule associated protein which contributes to the normal function of this intracellular support structure. Under pathogenic conditions, tau is highly phosphorylated reducing its ability to bind to microtubules [<xref ref-type="bibr" rid="B60">40</xref>] and favoring the formation of protein aggregates.</p><p>As a part of the inflammatory response, gliosis is a common feature of AD. Activated astrocytes and microglia are characteristically found in abundance near neurons and plaques. Besides, AD brains show increased expression of several pro-inflammatory cytokines which are hardly found in normal brains [<xref ref-type="bibr" rid="B61">61</xref>&#x02013;<xref ref-type="bibr" rid="B64">64</xref>]. The main hypothesis proposes the chronic inflammatory reaction as a response to the accumulation of A<italic>&#x003b2;</italic> plaques and tangles [<xref ref-type="bibr" rid="B65">65</xref>]. Although initial inflammatory response can be beneficial, chronic activation of astrocytes and microglia has been shown to induce necrosis in adjacent neurons by releasing reactive oxygen intermediates, nitric oxide, proteolytic enzymes, complementary factors, or excitatory amino acids [<xref ref-type="bibr" rid="B66">66</xref>].</p><p>A<italic>&#x003b2;</italic> and their precursor APP are potent activators of glial cells [<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>]. Thus, A<italic>&#x003b2;</italic> binds to the microglial cell surface regulating extracellular signal regulated kinase (ERK) and mitogen-activated protein kinase (MAPK) pathways which induces proinflammatory gene expression leading to cytokine and chemokine production [<xref ref-type="bibr" rid="B69">69</xref>]. Several chemokines and their receptors have been found to be upregulated in the AD brain. For example, macrophage inflammatory protein (MIP)-1<italic>&#x003b1;</italic> has been detected in reactive astrocytes nearby A<italic>&#x003b2;</italic> plaques [<xref ref-type="bibr" rid="B70">70</xref>]. In the same manner, changes in levels of many cytokines have been described not only in AD brains but also in blood and cerebrospinal fluid from patients. Thus, increased levels of IL-1<italic>&#x003b1;</italic>, IL-1<italic>&#x003b2;</italic>, IL-6, TNF-<italic>&#x003b1;</italic>, and GM-SF have been reported in brain tissue [<xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B72">72</xref>]. In serum from patients, an increase in eotaxin, a cytokine recently linked to adult neurogenesis and ageing has been also detected [<xref ref-type="bibr" rid="B28">28</xref>] and, correlating to this, an increase in the expression of its receptor, CCR3, has been found in AD brains, especially in microglia [<xref ref-type="bibr" rid="B73">73</xref>]. Importantly, several works describe interactions between components of the senile plaques and cytokines, which could be generating a positive feedback loop for the neuroinflammatory process [<xref ref-type="bibr" rid="B74">74</xref>]. For example, A<italic>&#x003b2;</italic> protein is able to potentiate the secretion of IL-6 and IL-8 under several conditions [<xref ref-type="bibr" rid="B75">75</xref>]. Similarly, astrocytes might be activated by A<italic>&#x003b2;</italic> [<xref ref-type="bibr" rid="B76">76</xref>], contributing to generating a proinflammatory environment via the liberation of several cytokines and chemokines.</p><p>However, in some situations the role of microglia has been shown to be beneficial, since the activation of this population can decrease the accumulation of A<italic>&#x003b2;</italic> thanks to their phagocytic ability which facilitates the clearance and degradation of the aggregates [<xref ref-type="bibr" rid="B77">77</xref>]. Besides, microglia can be beneficial too through the secretion of growth factors such as the glia-derived neurotrophic factor (GDNF) which favors neuron survival [<xref ref-type="bibr" rid="B78">78</xref>]. Similarly, a relatively unknown cytokine, fractalkine, which has been demonstrated to have important neuroprotective characteristics, has been recently linked to the disease. Thus, fractalkine signaling (with its only receptor CX<sub>3</sub>CR1) has been found to be altered in AD brains in which reduced levels of the cytokine has been described [<xref ref-type="bibr" rid="B79">79</xref>].</p><p>Finally, it is noteworthy to keep in mind that although neurons have been traditionally believed to be passive bystanders in neuroinflammation, they seem to contribute to the production of neuroinflammatory molecules, a phenomenon that could be relevant in AD. Thus, the production of IL-1, IL-6, and TNF-<italic>&#x003b1;</italic> by neurons has been reported. Indeed, these neuronal chemokines act as messengers between neurons and glial cells (for a review, see [<xref ref-type="bibr" rid="B80">80</xref>]).</p><p>As neuroinflammation represents an important hallmark in AD and, as it has been shown in <xref ref-type="sec" rid="sec2">Section 2</xref>, it has a remarkable influence on adult neurogenesis, modulating the inflammatory environment could be beneficial not only for improving the deficits directly provoked by the disease but also for stimulating the endogenous ability of the brain for repairing the damage. In this sense, it is important to highlight that, especially in AD, understanding the role of adult neurogenesis is of great importance considering that one of the neurogenic zones is the hippocampus, structure responsible for cognitive and learning capacities which is largely affected in AD patients.</p><p>To date, it is not fully understood how adult neurogenesis is affected in neurodegenerative disorders. In AD, contradictory results have been obtained from the study of several animal models and the study of brain tissue by biochemical and histological approaches. Different effects on proliferation, differentiation, and survival have been reported in AD transgenic animal models with mutations in APP and tau or in both (for a review, see [<xref ref-type="bibr" rid="B81">81</xref>]). Besides, alterations affecting NPCs and differentiation of newborn neurons have been described in a glycogen-synthase kinase 3 overexpressing mouse model (GSK-3<italic>&#x003b2;</italic> has been proposed as a key protein in AD [<xref ref-type="bibr" rid="B82">82</xref>]), with an important role of microglia as a mediator of these damaging effects [<xref ref-type="bibr" rid="B83">83</xref>, <xref ref-type="bibr" rid="B84">84</xref>] among which, morphology alterations of newborn neurons are included [<xref ref-type="bibr" rid="B85">85</xref>]. In humans, first data were obtained by Nagy and colleagues in 1997 [<xref ref-type="bibr" rid="B86">86</xref>]. In this pioneer work, the authors reported an increase in Ki-67 marker (staining proliferating cells) in the hippocampus from AD patients. In 2004, Jin et al. confirmed this result restricting it specifically to neurons [<xref ref-type="bibr" rid="B87">87</xref>]. However, in 2006, another group, although reported an increase in the proliferative status of presenile AD brains, they demonstrated that these precursors finally differentiated into glial cells [<xref ref-type="bibr" rid="B88">88</xref>]. </p><p>Consequently, although adult neurogenesis remains an unknown field to be further explored in Alzheimer disease, it is likely to be affected in the disease. Taking into account that this process is known to contribute to learning and memory [<xref ref-type="bibr" rid="B89">89</xref>&#x02013;<xref ref-type="bibr" rid="B91">91</xref>], an appropriate form to improve the subsequent deficits in cognitive functions associated to AD would result from modulating factors, such as those implicated in neuroinflammation, directly related to the correct formation of the newborn neurons. Finally, we cannot forget that adult neurogenesis declines with age, being a not so common event in the elderly [<xref ref-type="bibr" rid="B92">92</xref>], a fact that reinforces even more the idea of preserving or stimulating it as a brain repair mechanism.</p></sec><sec id="sec4"><title>4. Therapeutic Approaches</title><p>Based on the evidence that involves neuroinflammation in the pathogenesis of Alzheimer disease, researchers have focused their efforts on the development of anti-inflammatory drugs as a treatment option for patients with AD. Drugs such as the NSAIDs and glucocorticoid steroids have been studied.</p><sec id="sec4.1"><title>4.1. NSAIDs</title><p>NSAIDs is the abbreviation for &#x0201c;nonsteroidal anti-inflammatory drugs.&#x0201d; They constitute a large family of compounds which includes the salicylate, propionic acid, acetic acid, fenamate, oxicam, and the COX-2 inhibitor classes (enzymes which regulate the homeostatic production of prostanoids, implicated in the inflammatory response) [<xref ref-type="bibr" rid="B36">36</xref>]. Epidemiological evidences indicate that NSAIDs may lower the risk of developing AD [<xref ref-type="bibr" rid="B93">93</xref>&#x02013;<xref ref-type="bibr" rid="B95">95</xref>], since patients suffering from rheumatoid arthritis and osteoarthritis have been shown to inversely correlate with the risk of develop AD. Although beneficial effects have been observed both <italic>in vitro</italic> and <italic>in vivo</italic> (for a review, see [<xref ref-type="bibr" rid="B80">80</xref>]), unfortunately, clinical trials of NSAIDs in AD patients have not been very fruitful [<xref ref-type="bibr" rid="B96">96</xref>], especially in the case of COX-2 inhibitors. Thus, COX-2 inhibitor rofecoxib and the COX-1 and COX-2 inhibitor naproxen, were unable to slow the progression of the disease in patients with mild-moderate AD [<xref ref-type="bibr" rid="B97">97</xref>]. As a possible hypothesis, it could be postulated that NSAIDs might be useful to prevent the pathology but ineffective once the disease occurs.</p></sec><sec id="sec4.2"><title>4.2. Glucocorticoid Steroids</title><p>These compounds are considered as potent anti-inflammatory agents that modulate the transcription of several inflammatory molecules reducing, for example, the expression of proinflammatory cytokines and complement proteins [<xref ref-type="bibr" rid="B98">98</xref>]. However, the results obtained in AD patients have not been very promising. Thus, the use of some glucocorticoid steroids, such as prednisone, has not revealed any benefit in terms of slowing cognitive decline [<xref ref-type="bibr" rid="B99">99</xref>].</p><p>However, other therapies have been developed not directly directed to reduce inflammation but to the main targets that induce the chronic activation of these mechanisms, such as A<italic>&#x003b2;</italic> plaques or tau protein. </p></sec><sec id="sec4.3"><title>4.3. A<italic>&#x003b2;</italic>-Based Immunization Strategies</title><p>the efficacy of these therapies has been demonstrated in mouse models of the disease. In 1999, Schenk and colleagues proved in an APP mutant mice that A<italic>&#x003b2;</italic>-directed vaccination prevented the development of neuritic A<italic>&#x003b2;</italic> plaques reducing them in older animals [<xref ref-type="bibr" rid="B100">100</xref>]. Furthermore, vaccination was effective in reducing age-dependent learning deficits which correlated with reductions in both soluble A<italic>&#x003b2;</italic> and tau [<xref ref-type="bibr" rid="B101">101</xref>]. Although APP model does not recapitulate all common features of AD, they resemble an early preclinical phase of the disease, which may be the optimal phase to initiate a therapy for preventing the disorder [<xref ref-type="bibr" rid="B102">102</xref>]. Importantly, efficacy of the vaccine was also found in a nonhuman primate, the Caribbean vervet [<xref ref-type="bibr" rid="B103">103</xref>]. Regarding the promising results obtained in animal models, a clinical trial was launched with AN-1792 containing preaggregated synthetic A<italic>&#x003b2;</italic><sub>42</sub> and the adjuvant QS-21 [<xref ref-type="bibr" rid="B104">104</xref>]. Although 6% of the patients developed meningoencephalitis, some others developed A<italic>&#x003b2;</italic>-antibody titres that correlated with a slow cognitive decline [<xref ref-type="bibr" rid="B105">105</xref>], and this result encouraged the development of several antibody fragments and humanized A<italic>&#x003b2;</italic>-specific antibodies, which are currently in various stages of clinical trials [<xref ref-type="bibr" rid="B102">102</xref>]. Time will tell whether these therapies are effective enough to halt the disease.</p></sec><sec id="sec4.4"><title>4.4. Tau-Based Immunization Approaches</title><p>First approach applying tau-based immunization was carried out by Rosenmann and colleagues in 2006 by injecting C57BL/6 wild-type animals with full-recombinant human tau. The experiments are unsuccessful since the vaccination caused encephalitis [<xref ref-type="bibr" rid="B106">106</xref>]. Subsequently, other groups tried active immunization approaches using tau phosphopeptides, obtaining promising results in tau transgenic models, in which they were able to prevent tau pathology in the absence of obvious side effects (for a review, see [<xref ref-type="bibr" rid="B107">107</xref>]). However, one of the main problems derived from these studies is the difficulty to translate them into clinical practice. This is due to the fact that the vaccinations were observed to prevent tau-related problems when administered prior to the appearance of any pathology or cognitive deficit, something that, nowadays, would be impossible regarding the current diagnosis methods. At present, the tau-targeted therapies that are in clinical trials target tau phosphorylation by GSK-3, microtubule stability, and aggregation [<xref ref-type="bibr" rid="B108">108</xref>].</p><p>Finally, it is important to highlight that considering that A<italic>&#x003b2;</italic> pathology depends on the presence of tau [<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B110">110</xref>] and that A<italic>&#x003b2;</italic> deposition is absent in many tauopathies (neurodegenerative diseases associated with the pathological aggregation of tau), it is absolutely necessary to pursue a tau-targeted treatment probably in combination with an A<italic>&#x003b2;</italic>-targeting approach.</p></sec></sec><sec id="sec5"><title>5. Concluding Remarks</title><p>Although mechanisms underlaying Alzheimer disease remain unclear, neuroinflammation seems to be a common feature to neurodegenerative diseases with an important contribution to the pathology, affecting among others, physiological processes with a repairing function such as the adult neurogenesis process. Thus, modulating neuroinflammation by targeting causing agents or/and trying to ameliorate their harmful effects could be of great importance to possibly, prevent AD pathology and contribute to stimulate endogenous repairing mechanisms as the formation of new neurons. </p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Grants from the Spanish Ministry of Science and Technology (SAF2010-15525), the Comunidad de Madrid (S-SAL-0253-2006), the Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red sobre Enfermedades Neurodegenerativas (CIBERNED, ISCIII), and the Spanish Plan Nacional.</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>WJ</given-names></name><name><surname>Walter</surname><given-names>SA</given-names></name><name><surname>Pennell</surname><given-names>NA</given-names></name></person-group><article-title>Reactive microgliosis</article-title><source><italic>Progress in Neurobiology</italic></source><year>1999</year><volume>57</volume><issue>6</issue><fpage>563</fpage><lpage>581</lpage><pub-id pub-id-type="other">2-s2.0-0033044951</pub-id><pub-id pub-id-type="pmid">10221782</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latov</surname><given-names>N</given-names></name><name><surname>Nilaver</surname><given-names>G</given-names></name><name><surname>Zimmerman</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Fibrillary astrocytes proliferate in response to brain injury. A study combining immunoperoxidase technique for glial fibrillary acidic protein and radioautography of tritiated thymidine</article-title><source><italic>Developmental Biology</italic></source><year>1979</year><volume>72</volume><issue>2</issue><fpage>381</fpage><lpage>384</lpage><pub-id pub-id-type="other">2-s2.0-0018628641</pub-id><pub-id pub-id-type="pmid">389711</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyake</surname><given-names>T</given-names></name><name><surname>Kitamura</surname><given-names>T</given-names></name><name><surname>Takamatsu</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name></person-group><article-title>A quantitative analysis of human astrocytosis</article-title><source><italic>Acta Neuropathologica</italic></source><year>1988</year><volume>75</volume><issue>5</issue><fpage>535</fpage><lpage>537</lpage><pub-id pub-id-type="other">2-s2.0-0023869885</pub-id><pub-id pub-id-type="pmid">3287835</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lossinsky</surname><given-names>AS</given-names></name><name><surname>Shivers</surname><given-names>RR</given-names></name></person-group><article-title>Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review</article-title><source><italic>Histology and Histopathology</italic></source><year>2004</year><volume>19</volume><issue>2</issue><fpage>535</fpage><lpage>564</lpage><pub-id pub-id-type="other">2-s2.0-1842588603</pub-id><pub-id pub-id-type="pmid">15024715</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaper</surname><given-names>SD</given-names></name><name><surname>Giusti</surname><given-names>P</given-names></name><name><surname>Facci</surname><given-names>L</given-names></name></person-group><article-title>Microglia and mast cells: two tracks on the road to neuroinflammation</article-title><source><italic>FASEB Journal</italic></source><year>2012</year><volume>26</volume><fpage>3103</fpage><lpage>3117</lpage><pub-id pub-id-type="pmid">22516295</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name></person-group><article-title>Innate immunity in the central nervous system</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2012</year><volume>122</volume><fpage>1164</fpage><lpage>1171</lpage><pub-id pub-id-type="pmid">22466658</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettenmann</surname><given-names>H</given-names></name><name><surname>Hanisch</surname><given-names>UK</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Verkhratsky</surname><given-names>A</given-names></name></person-group><article-title>Physiology of microglia</article-title><source><italic>Physiological Reviews</italic></source><year>2011</year><volume>91</volume><fpage>461</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">21527731</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wee Yong</surname><given-names>V</given-names></name></person-group><article-title>Inflammation in neurological disorders: a help or a hindrance?</article-title><source><italic>Neuroscientist</italic></source><year>2010</year><volume>16</volume><issue>4</issue><fpage>408</fpage><lpage>420</lpage><pub-id pub-id-type="other">2-s2.0-77956302879</pub-id><pub-id pub-id-type="pmid">20817918</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Holgado</surname><given-names>E</given-names></name><name><surname>Molina-Holgado</surname><given-names>F</given-names></name></person-group><article-title>Mending the broken brain: neuroimmune interactions in neurogenesis</article-title><source><italic>Journal of Neurochemistry</italic></source><year>2010</year><volume>114</volume><issue>5</issue><fpage>1277</fpage><lpage>1290</lpage><pub-id pub-id-type="other">2-s2.0-77955131100</pub-id><pub-id pub-id-type="pmid">20534007</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streit</surname><given-names>WJ</given-names></name><name><surname>Mrak</surname><given-names>RE</given-names></name><name><surname>Griffin</surname><given-names>WST</given-names></name></person-group><article-title>Microglia and neuroinflammation: a pathological perspective</article-title><source><italic>Journal of Neuroinflammation</italic></source><year>2004</year><volume>1, article 14</volume><pub-id pub-id-type="other">2-s2.0-7744224673</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank-Cannon</surname><given-names>TC</given-names></name><name><surname>Alto</surname><given-names>LT</given-names></name><name><surname>McAlpine</surname><given-names>FE</given-names></name><name><surname>Tansey</surname><given-names>MG</given-names></name></person-group><article-title>Does neuroinflammation fan the flame in neurodegenerative diseases?</article-title><source><italic>Molecular Neurodegeneration</italic></source><year>2009</year><volume>4</volume><issue>1, article 47</issue><pub-id pub-id-type="other">2-s2.0-72449204160</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doetsch</surname><given-names>F</given-names></name><name><surname>Hen</surname><given-names>R</given-names></name></person-group><article-title>Young and excitable: the function of new neurons in the adult mammalian brain</article-title><source><italic>Current Opinion in Neurobiology</italic></source><year>2005</year><volume>15</volume><issue>1</issue><fpage>121</fpage><lpage>128</lpage><pub-id pub-id-type="other">2-s2.0-13844264520</pub-id><pub-id pub-id-type="pmid">15721754</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winner</surname><given-names>B</given-names></name><name><surname>Kohl</surname><given-names>Z</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Neurodegenerative disease and adult neurogenesis</article-title><source><italic>European Journal of Neuroscience</italic></source><year>2011</year><volume>33</volume><issue>6</issue><fpage>1139</fpage><lpage>1151</lpage><pub-id pub-id-type="other">2-s2.0-79952579942</pub-id><pub-id pub-id-type="pmid">21395858</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>I</given-names></name><name><surname>Barlati</surname><given-names>S</given-names></name><name><surname>Bosetti</surname><given-names>F</given-names></name></person-group><article-title>Effects of neuroinflammation on the regenerative capacity of brain stem cells</article-title><source><italic>Journal of Neurochemistry</italic></source><year>2011</year><volume>116</volume><issue>6</issue><fpage>947</fpage><lpage>956</lpage><pub-id pub-id-type="other">2-s2.0-79952444584</pub-id><pub-id pub-id-type="pmid">21198642</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>G</given-names></name><name><surname>Pluchino</surname><given-names>S</given-names></name></person-group><article-title>Neural stem cells: guardians of the brain</article-title><source><italic>Nature Cell Biology</italic></source><year>2007</year><volume>9</volume><issue>9</issue><fpage>1031</fpage><lpage>1034</lpage><pub-id pub-id-type="other">2-s2.0-34548358822</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanisch</surname><given-names>UK</given-names></name><name><surname>Kettenmann</surname><given-names>H</given-names></name></person-group><article-title>Microglia: active sensor and versatile effector cells in the normal and pathologic brain</article-title><source><italic>Nature Neuroscience</italic></source><year>2007</year><volume>10</volume><issue>11</issue><fpage>1387</fpage><lpage>1394</lpage><pub-id pub-id-type="other">2-s2.0-35548986304</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sierra</surname><given-names>A</given-names></name><name><surname>Encinas</surname><given-names>JM</given-names></name><name><surname>Deudero</surname><given-names>JJP</given-names></name><etal/></person-group><article-title>Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis</article-title><source><italic>Cell Stem Cell</italic></source><year>2010</year><volume>7</volume><issue>4</issue><fpage>483</fpage><lpage>495</lpage><pub-id pub-id-type="other">2-s2.0-77957328867</pub-id><pub-id pub-id-type="pmid">20887954</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biebl</surname><given-names>M</given-names></name><name><surname>Cooper</surname><given-names>CM</given-names></name><name><surname>Winkler</surname><given-names>J</given-names></name><name><surname>Kuhn</surname><given-names>HG</given-names></name></person-group><article-title>Analysis of neurogenesis and programmed cell death reveals a self- renewing capacity in the adult rat brain</article-title><source><italic>Neuroscience Letters</italic></source><year>2000</year><volume>291</volume><issue>1</issue><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="other">2-s2.0-0034623304</pub-id><pub-id pub-id-type="pmid">10962143</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>HA</given-names></name><name><surname>Mckay</surname><given-names>RDG</given-names></name></person-group><article-title>Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus</article-title><source><italic>Journal of Comparative Neurology</italic></source><year>2001</year><volume>435</volume><issue>4</issue><fpage>406</fpage><lpage>417</lpage><pub-id pub-id-type="other">2-s2.0-0035833068</pub-id><pub-id pub-id-type="pmid">11406822</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayer</surname><given-names>AG</given-names></name><name><surname>Ford</surname><given-names>AA</given-names></name><name><surname>Cleaver</surname><given-names>KM</given-names></name><name><surname>Yassaee</surname><given-names>M</given-names></name><name><surname>Cameron</surname><given-names>HA</given-names></name></person-group><article-title>Short-term and long-term survival of new neurons in the rat dentate gyrus</article-title><source><italic>Journal of Comparative Neurology</italic></source><year>2003</year><volume>460</volume><issue>4</issue><fpage>563</fpage><lpage>572</lpage><pub-id pub-id-type="other">2-s2.0-0038301570</pub-id><pub-id pub-id-type="pmid">12717714</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempermann</surname><given-names>G</given-names></name><name><surname>Gast</surname><given-names>D</given-names></name><name><surname>Kronenberg</surname><given-names>G</given-names></name><name><surname>Yamaguchi</surname><given-names>M</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Early determination and long-term persistence of adult-generated new neurons in the hippocampus of mice</article-title><source><italic>Development</italic></source><year>2003</year><volume>130</volume><issue>2</issue><fpage>391</fpage><lpage>399</lpage><pub-id pub-id-type="other">2-s2.0-0037262305</pub-id><pub-id pub-id-type="pmid">12466205</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosher</surname><given-names>KI</given-names></name><name><surname>Andres</surname><given-names>RH</given-names></name><name><surname>Fukuhara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Neural progenitor cells regulate microglia functions and activity</article-title><source><italic>Nature Neuroscience</italic></source><year>2012</year><volume>15</volume><fpage>1485</fpage><lpage>1487</lpage></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biber</surname><given-names>K</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Boddeke</surname><given-names>HWGM</given-names></name></person-group><article-title>Neuronal &#x0201c;On&#x0201d; and &#x0201c;Off&#x0201d; signals control microglia</article-title><source><italic>Trends in Neurosciences</italic></source><year>2007</year><volume>30</volume><issue>11</issue><fpage>596</fpage><lpage>602</lpage><pub-id pub-id-type="other">2-s2.0-35748939409</pub-id><pub-id pub-id-type="pmid">17950926</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walton</surname><given-names>NM</given-names></name><name><surname>Sutter</surname><given-names>BM</given-names></name><name><surname>Laywell</surname><given-names>ED</given-names></name><etal/></person-group><article-title>Microglia instruct subventricular zone neurogenesis</article-title><source><italic>Glia</italic></source><year>2006</year><volume>54</volume><issue>8</issue><fpage>815</fpage><lpage>825</lpage><pub-id pub-id-type="other">2-s2.0-33750550678</pub-id><pub-id pub-id-type="pmid">16977605</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>FJ</given-names></name><name><surname>McKercher</surname><given-names>SR</given-names></name><name><surname>Imitola</surname><given-names>J</given-names></name><etal/></person-group><article-title>At the interface of the immune system and the nervous system: how neuroinflammation modulates the fate of neural progenitors in vivo</article-title><source><italic>Ernst Schering Research Foundation workshop.</italic></source><year>2005</year><issue>53</issue><fpage>83</fpage><lpage>114</lpage><pub-id pub-id-type="other">2-s2.0-33644828334</pub-id><pub-id pub-id-type="pmid">16315610</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Perez</surname><given-names>O</given-names></name><name><surname>Qui&#x000f1;ones-Hinojosa</surname><given-names>A</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>JM</given-names></name></person-group><article-title>Immunological control of adult neural stem cells</article-title><source><italic>Journal of Stem Cells</italic></source><year>2010</year><volume>5</volume><issue>1</issue><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="other">2-s2.0-78650394492</pub-id><pub-id pub-id-type="pmid">20861925</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>A</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>C</given-names></name><name><surname>Steigleder</surname><given-names>T</given-names></name><etal/></person-group><article-title>The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis</article-title><source><italic>Journal of Clinical Investigation</italic></source><year>2005</year><volume>115</volume><issue>8</issue><fpage>2083</fpage><lpage>2098</lpage><pub-id pub-id-type="other">2-s2.0-23644445498</pub-id><pub-id pub-id-type="pmid">16007267</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villeda</surname><given-names>SA</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>Mosher</surname><given-names>KI</given-names></name><etal/></person-group><article-title>The ageing systemic milieu negatively regulates neurogenesis and cognitive function</article-title><source><italic>Nature</italic></source><year>2011</year><volume>477</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">21886162</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCombe</surname><given-names>PA</given-names></name><name><surname>Henderson</surname><given-names>RD</given-names></name></person-group><article-title>The role of immune and inflammatory mechanisms in ALS</article-title><source><italic>Current Molecular Medicine</italic></source><year>2011</year><volume>11</volume><issue>3</issue><fpage>246</fpage><lpage>254</lpage><pub-id pub-id-type="other">2-s2.0-79953297965</pub-id><pub-id pub-id-type="pmid">21375489</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>E</given-names></name></person-group><article-title>Multiple sclerosis</article-title><source><italic>Advances in Experimental Medicine and Biology</italic></source><year>2012</year><volume>724</volume><fpage>222</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">22411246</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilms</surname><given-names>H</given-names></name><name><surname>Zecca</surname><given-names>L</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Sievers</surname><given-names>J</given-names></name><name><surname>Deuschl</surname><given-names>G</given-names></name><name><surname>Lucius</surname><given-names>R</given-names></name></person-group><article-title>Inflammation in Parkinson&#x02019;s diseases and other neurodegenerative diseases: cause and therapeutic implications</article-title><source><italic>Current Pharmaceutical Design</italic></source><year>2007</year><volume>13</volume><issue>18</issue><fpage>1925</fpage><lpage>1928</lpage><pub-id pub-id-type="other">2-s2.0-34347357758</pub-id><pub-id pub-id-type="pmid">17584117</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doorn</surname><given-names>KJ</given-names></name><name><surname>Lucassen</surname><given-names>PJ</given-names></name><name><surname>Boddeke</surname><given-names>HW</given-names></name></person-group><article-title>Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease</article-title><source><italic>Progress in Neurobiology</italic></source><year>2012</year><volume>98</volume><fpage>222</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">22732265</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palace</surname><given-names>J</given-names></name></person-group><article-title>Inflammation versus neurodegeneration: consequences for treatment</article-title><source><italic>Journal of the Neurological Sciences</italic></source><year>2007</year><volume>259</volume><issue>1-2</issue><fpage>46</fpage><lpage>49</lpage><pub-id pub-id-type="other">2-s2.0-34447095904</pub-id><pub-id pub-id-type="pmid">17418237</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wimo</surname><given-names>A</given-names></name><name><surname>Jonsson</surname><given-names>L</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name></person-group><article-title>An estimate of the worldwide prevalence and direct costs of dementia in 2003</article-title><source><italic>Dementia and Geriatric Cognitive Disorders</italic></source><year>2006</year><volume>21</volume><issue>3</issue><fpage>175</fpage><lpage>181</lpage><pub-id pub-id-type="other">2-s2.0-32044447659</pub-id><pub-id pub-id-type="pmid">16401889</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>LE</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Gilley</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Decline of language among women and men with alzheimer&#x02019;s disease</article-title><source><italic>Journals of Gerontology Series B</italic></source><year>2000</year><volume>55</volume><issue>6</issue><fpage>P354</fpage><lpage>P360</lpage><pub-id pub-id-type="other">2-s2.0-0034541287</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio-Perez</surname><given-names>JM</given-names></name><name><surname>Morillas-Ruiz</surname><given-names>JM</given-names></name></person-group><article-title>A review: inflammatory process in Alzheimer's disease, role of cytokines</article-title><source><italic>The ScientificWorldJournal</italic></source><year>2012</year><volume>2012</volume><fpage>15 pages</fpage><pub-id pub-id-type="publisher-id">756357</pub-id></element-citation></ref><ref id="B57"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>F</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name></person-group><article-title>The role of glycogen synthase kinase 3 in the early stages of Alzheimers&#x02019; disease</article-title><source><italic>FEBS Letters</italic></source><year>2008</year><volume>582</volume><issue>28</issue><fpage>3848</fpage><lpage>3854</lpage><pub-id pub-id-type="other">2-s2.0-55749106048</pub-id><pub-id pub-id-type="pmid">18955053</pub-id></element-citation></ref><ref id="B58"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loffler</surname><given-names>J</given-names></name><name><surname>Huber</surname><given-names>G</given-names></name></person-group><article-title>
<italic>&#x003b2;</italic>-Amyloid precursor protein isoforms in various rat brain regions and during brain development</article-title><source><italic>Journal of Neurochemistry</italic></source><year>1992</year><volume>59</volume><issue>4</issue><fpage>1316</fpage><lpage>1324</lpage><pub-id pub-id-type="other">2-s2.0-0026661087</pub-id><pub-id pub-id-type="pmid">1402883</pub-id></element-citation></ref><ref id="B59"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selkoe</surname><given-names>DJ</given-names></name><name><surname>Podlisny</surname><given-names>MB</given-names></name><name><surname>Joachim</surname><given-names>CL</given-names></name><etal/></person-group><article-title>
<italic>&#x003b2;</italic>-Amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1988</year><volume>85</volume><issue>19</issue><fpage>7341</fpage><lpage>7345</lpage><pub-id pub-id-type="other">2-s2.0-0001067847</pub-id><pub-id pub-id-type="pmid">3140239</pub-id></element-citation></ref><ref id="B60"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Hartley</surname><given-names>CL</given-names></name><name><surname>Pearce</surname><given-names>J</given-names></name><name><surname>Anderton</surname><given-names>BH</given-names></name></person-group><article-title>Phosphorylation of tau by glycogen synthase kinase-3<italic>&#x003b2;</italic> in intact mammalian cells: the effects on the organization and stability of microtubules</article-title><source><italic>Neuroscience</italic></source><year>1996</year><volume>73</volume><issue>4</issue><fpage>1145</fpage><lpage>1157</lpage><pub-id pub-id-type="other">2-s2.0-0029994754</pub-id><pub-id pub-id-type="pmid">8809831</pub-id></element-citation></ref><ref id="B37"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajmone-Cat</surname><given-names>MA</given-names></name><name><surname>Cacci</surname><given-names>E</given-names></name><name><surname>Ragazzoni</surname><given-names>Y</given-names></name><name><surname>Minghetti</surname><given-names>L</given-names></name><name><surname>Biagioni</surname><given-names>S</given-names></name></person-group><article-title>Pro-gliogenic effect of IL-1<italic>&#x003b1;</italic> in the differentiation of embryonic neural precursor cells in vitro</article-title><source><italic>Journal of Neurochemistry</italic></source><year>2010</year><volume>113</volume><issue>4</issue><fpage>1060</fpage><lpage>1072</lpage><pub-id pub-id-type="other">2-s2.0-77950943601</pub-id><pub-id pub-id-type="pmid">20236219</pub-id></element-citation></ref><ref id="B38"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Fu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Interleukin-1<italic>&#x003b2;</italic> mediates proliferation and differentiation of multipotent neural precursor cells through the activation of SAPK/JNK pathway</article-title><source><italic>Molecular and Cellular Neuroscience</italic></source><year>2007</year><volume>36</volume><issue>3</issue><fpage>343</fpage><lpage>354</lpage><pub-id pub-id-type="other">2-s2.0-35448977752</pub-id><pub-id pub-id-type="pmid">17822921</pub-id></element-citation></ref><ref id="B39"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>HF</given-names></name><name><surname>Treacy</surname><given-names>E</given-names></name><name><surname>Keohane</surname><given-names>AK</given-names></name><name><surname>Sullivan</surname><given-names>AM</given-names></name><name><surname>O'Keeffe</surname><given-names>GW</given-names></name><name><surname>Nolan</surname><given-names>YM</given-names></name></person-group><article-title>A role for interleukin-1beta in determining the lineage fate of embryonic rat hippocampal neural precursor cells</article-title><source><italic>Molecular and Cellular Neurosciences</italic></source><year>2012</year><volume>49</volume><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">22270046</pub-id></element-citation></ref><ref id="B40"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>MD</given-names></name><name><surname>Hein</surname><given-names>AM</given-names></name><name><surname>Moravan</surname><given-names>MJ</given-names></name><name><surname>Shaftel</surname><given-names>SS</given-names></name><name><surname>Olschowka</surname><given-names>JA</given-names></name><name><surname>O'Banion</surname><given-names>MK</given-names></name></person-group><article-title>Adult murine hippocampal neurogenesis is inhibited by sustained IL-1beta and not rescued by voluntary running</article-title><source><italic>Brain, Behavior, and Immunity</italic></source><year>2012</year><volume>26</volume><fpage>292</fpage><lpage>300</lpage></element-citation></ref><ref id="B41"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butovsky</surname><given-names>O</given-names></name><name><surname>Ziv</surname><given-names>Y</given-names></name><name><surname>Schwartz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Microglia activated by IL-4 or IFN-<italic>&#x003b3;</italic> differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells</article-title><source><italic>Molecular and Cellular Neuroscience</italic></source><year>2006</year><volume>31</volume><issue>1</issue><fpage>149</fpage><lpage>160</lpage><pub-id pub-id-type="other">2-s2.0-30044434850</pub-id><pub-id pub-id-type="pmid">16297637</pub-id></element-citation></ref><ref id="B42"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valli&#x000e9;res</surname><given-names>L</given-names></name><name><surname>Campbell</surname><given-names>IL</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Sawchenko</surname><given-names>PE</given-names></name></person-group><article-title>Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6</article-title><source><italic>Journal of Neuroscience</italic></source><year>2002</year><volume>22</volume><issue>2</issue><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="other">2-s2.0-0037079993</pub-id><pub-id pub-id-type="pmid">11784794</pub-id></element-citation></ref><ref id="B43"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monje</surname><given-names>ML</given-names></name><name><surname>Toda</surname><given-names>H</given-names></name><name><surname>Palmer</surname><given-names>TD</given-names></name></person-group><article-title>Inflammatory blockade restores adult hippocampal neurogenesis</article-title><source><italic>Science</italic></source><year>2003</year><volume>302</volume><issue>5651</issue><fpage>1760</fpage><lpage>1765</lpage><pub-id pub-id-type="other">2-s2.0-0345189366</pub-id><pub-id pub-id-type="pmid">14615545</pub-id></element-citation></ref><ref id="B44"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkho</surname><given-names>BZ</given-names></name><name><surname>Song</surname><given-names>H</given-names></name><name><surname>Aimone</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation</article-title><source><italic>Stem Cells and Development</italic></source><year>2006</year><volume>15</volume><issue>3</issue><fpage>407</fpage><lpage>421</lpage><pub-id pub-id-type="other">2-s2.0-33746255997</pub-id><pub-id pub-id-type="pmid">16846377</pub-id></element-citation></ref><ref id="B45"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>O</given-names></name><name><surname>Gong</surname><given-names>X</given-names></name><name><surname>Rose-John</surname><given-names>S</given-names></name><name><surname>Heese</surname><given-names>K</given-names></name></person-group><article-title>Interleukin-6 and neural stem cells: more than gliogenesis</article-title><source><italic>Molecular Biology of the Cell</italic></source><year>2009</year><volume>20</volume><issue>1</issue><fpage>188</fpage><lpage>199</lpage><pub-id pub-id-type="other">2-s2.0-61849112508</pub-id><pub-id pub-id-type="pmid">18971377</pub-id></element-citation></ref><ref id="B46"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacci</surname><given-names>E</given-names></name><name><surname>Ajmone-Cat</surname><given-names>MA</given-names></name><name><surname>Anelli</surname><given-names>T</given-names></name><name><surname>Biagioni</surname><given-names>S</given-names></name><name><surname>Minghetti</surname><given-names>L</given-names></name></person-group><article-title>In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia</article-title><source><italic>Glia</italic></source><year>2008</year><volume>56</volume><issue>4</issue><fpage>412</fpage><lpage>425</lpage><pub-id pub-id-type="other">2-s2.0-38949139570</pub-id><pub-id pub-id-type="pmid">18186084</pub-id></element-citation></ref><ref id="B47"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiyota</surname><given-names>T</given-names></name><name><surname>Ingraham</surname><given-names>KL</given-names></name><name><surname>Swan</surname><given-names>RJ</given-names></name><name><surname>Jacobsen</surname><given-names>MT</given-names></name><name><surname>Andrews</surname><given-names>SJ</given-names></name><name><surname>Ikezu</surname><given-names>T</given-names></name></person-group><article-title>AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice</article-title><source><italic>Gene Therapy</italic></source><year>2011</year><volume>19</volume><fpage>724</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">21918553</pub-id></element-citation></ref><ref id="B48"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YP</given-names></name><name><surname>Lin</surname><given-names>HI</given-names></name><name><surname>Tzeng</surname><given-names>SF</given-names></name></person-group><article-title>Tumor necrosis factor-<italic>&#x003b1;</italic> and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture</article-title><source><italic>Brain Research</italic></source><year>2005</year><volume>1054</volume><issue>2</issue><fpage>152</fpage><lpage>158</lpage><pub-id pub-id-type="other">2-s2.0-24044485264</pub-id><pub-id pub-id-type="pmid">16054598</pub-id></element-citation></ref><ref id="B49"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Hur</surname><given-names>T</given-names></name><name><surname>Ben-Menachem</surname><given-names>O</given-names></name><name><surname>Furer</surname><given-names>V</given-names></name><name><surname>Einstein</surname><given-names>O</given-names></name><name><surname>Mizrachi-Kol</surname><given-names>R</given-names></name><name><surname>Grigoriadis</surname><given-names>N</given-names></name></person-group><article-title>Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells</article-title><source><italic>Molecular and Cellular Neuroscience</italic></source><year>2003</year><volume>24</volume><issue>3</issue><fpage>623</fpage><lpage>631</lpage><pub-id pub-id-type="other">2-s2.0-0344737625</pub-id><pub-id pub-id-type="pmid">14664813</pub-id></element-citation></ref><ref id="B50"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>G</given-names></name><name><surname>Goldshmit</surname><given-names>Y</given-names></name><name><surname>Turnley</surname><given-names>AM</given-names></name></person-group><article-title>Interferon-<italic>&#x003b3;</italic> but not TNF<italic>&#x003b1;</italic> promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells</article-title><source><italic>Experimental Neurology</italic></source><year>2004</year><volume>187</volume><issue>1</issue><fpage>171</fpage><lpage>177</lpage><pub-id pub-id-type="other">2-s2.0-1842663407</pub-id><pub-id pub-id-type="pmid">15081598</pub-id></element-citation></ref><ref id="B51"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Price</surname><given-names>J</given-names></name><name><surname>Modo</surname><given-names>M</given-names></name></person-group><article-title>Effect of inflammatory cytokines on major histocompatibility complex expression and differentiation of human neural stem/progenitor cells</article-title><source><italic>Stem Cells</italic></source><year>2008</year><volume>26</volume><issue>9</issue><fpage>2444</fpage><lpage>2454</lpage><pub-id pub-id-type="other">2-s2.0-55049090532</pub-id><pub-id pub-id-type="pmid">18635871</pub-id></element-citation></ref><ref id="B52"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachstetter</surname><given-names>AD</given-names></name><name><surname>Morganti</surname><given-names>JM</given-names></name><name><surname>Jernberg</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats</article-title><source><italic>Neurobiology of Aging</italic></source><year>2011</year><volume>32</volume><fpage>2030</fpage><lpage>2044</lpage><pub-id pub-id-type="pmid">20018408</pub-id></element-citation></ref><ref id="B53"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kr&#x000fc;ger</surname><given-names>C</given-names></name><name><surname>Laage</surname><given-names>R</given-names></name><name><surname>Pitzer</surname><given-names>C</given-names></name><name><surname>Sch&#x000e4;bitz</surname><given-names>WR</given-names></name><name><surname>Schneider</surname><given-names>A</given-names></name></person-group><article-title>The hematopoietic factor GM-CSF (Granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro</article-title><source><italic>BMC Neuroscience</italic></source><year>2007</year><volume>8, article 88</volume><pub-id pub-id-type="other">2-s2.0-41649105112</pub-id></element-citation></ref><ref id="B54"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wachs</surname><given-names>FP</given-names></name><name><surname>Winner</surname><given-names>B</given-names></name><name><surname>Couillard-Despres</surname><given-names>S</given-names></name><etal/></person-group><article-title>Transforming growth factor-<italic>&#x003b2;</italic>1 is a negative modulator of adult neurogenesis</article-title><source><italic>Journal of Neuropathology and Experimental Neurology</italic></source><year>2006</year><volume>65</volume><issue>4</issue><fpage>358</fpage><lpage>370</lpage><pub-id pub-id-type="other">2-s2.0-33744970240</pub-id><pub-id pub-id-type="pmid">16691117</pub-id></element-citation></ref><ref id="B55"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battista</surname><given-names>D</given-names></name><name><surname>Ferrari</surname><given-names>CC</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Pitossi</surname><given-names>FJ</given-names></name></person-group><article-title>Neurogenic niche modulation by activated microglia: transforming growth factor <italic>&#x003b2;</italic> increases neurogenesis in the adult dentate gyrus</article-title><source><italic>European Journal of Neuroscience</italic></source><year>2006</year><volume>23</volume><issue>1</issue><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="other">2-s2.0-33644960523</pub-id><pub-id pub-id-type="pmid">16420418</pub-id></element-citation></ref><ref id="B56"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>P</given-names></name><name><surname>Piantanida</surname><given-names>AP</given-names></name><name><surname>Pitossi</surname><given-names>F</given-names></name></person-group><article-title>Chronic expression of transforming growth factor-beta enhances adult neurogenesis</article-title><source><italic>NeuroImmunomodulation</italic></source><year>2010</year><volume>17</volume><issue>3</issue><fpage>200</fpage><lpage>201</lpage><pub-id pub-id-type="other">2-s2.0-76949088419</pub-id><pub-id pub-id-type="pmid">20134202</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sue T Griffin</surname><given-names>W</given-names></name><name><surname>Mrak</surname><given-names>RE</given-names></name></person-group><article-title>Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer&#x02019;s disease</article-title><source><italic>Journal of Leukocyte Biology</italic></source><year>2002</year><volume>72</volume><issue>2</issue><fpage>233</fpage><lpage>238</lpage><pub-id pub-id-type="other">2-s2.0-0036697305</pub-id><pub-id pub-id-type="pmid">12149413</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cacquevel</surname><given-names>M</given-names></name><name><surname>Lebeurrier</surname><given-names>N</given-names></name><name><surname>Ch&#x000e9;enne</surname><given-names>S</given-names></name><name><surname>Vivien</surname><given-names>D</given-names></name></person-group><article-title>Cytokines in neuroinflammation and Alzheimer&#x02019;s disease</article-title><source><italic>Current Drug Targets</italic></source><year>2004</year><volume>5</volume><issue>6</issue><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="other">2-s2.0-3442893295</pub-id><pub-id pub-id-type="pmid">15270199</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrak</surname><given-names>RE</given-names></name><name><surname>Griffin</surname><given-names>WST</given-names></name></person-group><article-title>Glia and their cytokines in progression of neurodegeneration</article-title><source><italic>Neurobiology of Aging</italic></source><year>2005</year><volume>26</volume><issue>3</issue><fpage>349</fpage><lpage>354</lpage><pub-id pub-id-type="other">2-s2.0-11444256801</pub-id><pub-id pub-id-type="pmid">15639313</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finch</surname><given-names>CE</given-names></name><name><surname>Morgan</surname><given-names>TE</given-names></name></person-group><article-title>Systemic inflammation, infection, ApoE alleles, and Alzheimer disease: a position paper</article-title><source><italic>Current Alzheimer Research</italic></source><year>2007</year><volume>4</volume><issue>2</issue><fpage>185</fpage><lpage>189</lpage><pub-id pub-id-type="other">2-s2.0-34147096369</pub-id><pub-id pub-id-type="pmid">17430245</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Town</surname><given-names>T</given-names></name><name><surname>Nikolic</surname><given-names>V</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name></person-group><article-title>The microglial &#x0201c;activation&#x0201d; continuum: from innate to adaptive responses</article-title><source><italic>Journal of Neuroinflammation</italic></source><year>2005</year><volume>2, article 24</volume><pub-id pub-id-type="other">2-s2.0-27744464859</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliday</surname><given-names>G</given-names></name><name><surname>Robinson</surname><given-names>SR</given-names></name><name><surname>Shepherd</surname><given-names>C</given-names></name><name><surname>Kril</surname><given-names>J</given-names></name></person-group><article-title>Alzheimer&#x02019;s disease and inflammation: a review of cellular and therapeutic mechanisms</article-title><source><italic>Clinical and Experimental Pharmacology and Physiology</italic></source><year>2000</year><volume>27</volume><issue>1-2</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="other">2-s2.0-0033951505</pub-id><pub-id pub-id-type="pmid">10696521</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>DW</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Mattiace</surname><given-names>LA</given-names></name><name><surname>Yen</surname><given-names>SH</given-names></name><name><surname>Brosnan</surname><given-names>C</given-names></name></person-group><article-title>Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer&#x02019;s disease</article-title><source><italic>Glia</italic></source><year>1993</year><volume>7</volume><issue>1</issue><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="other">2-s2.0-0027354484</pub-id><pub-id pub-id-type="pmid">8423065</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barger</surname><given-names>SW</given-names></name><name><surname>Harmon</surname><given-names>AD</given-names></name></person-group><article-title>Microglial activation by alzhelmer amyloid precursor protein and modulation by apolipoprotein E</article-title><source><italic>Nature</italic></source><year>1997</year><volume>388</volume><issue>6645</issue><fpage>878</fpage><lpage>881</lpage><pub-id pub-id-type="other">2-s2.0-0030610645</pub-id><pub-id pub-id-type="pmid">9278049</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>GJ</given-names></name><name><surname>Drego</surname><given-names>R</given-names></name><name><surname>Hakimian</surname><given-names>E</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name></person-group><article-title>Mechanisms of cell signaling and inflammation in Alzheimer&#x02019;s disease</article-title><source><italic>Current Drug Targets</italic></source><year>2005</year><volume>4</volume><issue>2</issue><fpage>247</fpage><lpage>256</lpage><pub-id pub-id-type="other">2-s2.0-21044448540</pub-id><pub-id pub-id-type="pmid">15853747</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>MQ</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>Chemokines/chemokine receptors in the central nervous system and Alzheimer&#x02019;s disease</article-title><source><italic>Journal of NeuroVirology</italic></source><year>1999</year><volume>5</volume><issue>1</issue><fpage>32</fpage><lpage>41</lpage><pub-id pub-id-type="other">2-s2.0-0032917904</pub-id><pub-id pub-id-type="pmid">10190688</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Meager</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Meyers</surname><given-names>R</given-names></name></person-group><article-title>Cytokines: interleukins</article-title><source><italic>Encyclopedia of Molecular Cell Biology and Molecular Medecine</italic></source><year>2004</year><publisher-loc>Weinheim, Germany</publisher-loc><publisher-name>Wilhey-VCH</publisher-name><fpage>115</fpage><lpage>151</lpage></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Meager</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Meyers</surname><given-names>R</given-names></name></person-group><article-title>Viral inhibitors and immune response mediators: the interferons</article-title><source><italic>Encyclopedia of Molecular Cell Biology and Molecular Medecine</italic></source><year>2005</year><publisher-loc>Weinheim, Germany</publisher-loc><publisher-name>Wilhey-VCH</publisher-name><fpage>387</fpage><lpage>421</lpage></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>MQ</given-names></name><name><surname>Qin</surname><given-names>SX</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Mackay</surname><given-names>CR</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name></person-group><article-title>Immunohistochemical study of the <italic>&#x003b2;</italic>-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer&#x02019;s disease brains</article-title><source><italic>American Journal of Pathology</italic></source><year>1998</year><volume>153</volume><issue>1</issue><fpage>31</fpage><lpage>37</lpage><pub-id pub-id-type="other">2-s2.0-0031848322</pub-id><pub-id pub-id-type="pmid">9665462</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGeer</surname><given-names>EG</given-names></name><name><surname>McGeer</surname><given-names>PL</given-names></name></person-group><article-title>Inflammation cytokines in the CNS</article-title><source><italic>CNS Drugs</italic></source><year>1997</year><volume>7</volume><issue>3</issue><fpage>214</fpage><lpage>228</lpage><pub-id pub-id-type="other">2-s2.0-0030897761</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forloni</surname><given-names>G</given-names></name><name><surname>Mangiarotti</surname><given-names>F</given-names></name><name><surname>Angeretti</surname><given-names>N</given-names></name><name><surname>Lucca</surname><given-names>E</given-names></name><name><surname>De Simoni</surname><given-names>MG</given-names></name></person-group><article-title>
<italic>&#x003b2;</italic>-amyloid fragment potentiates IL-6 and TNF-<italic>&#x003b1;</italic> secretion by LPS in astrocytes but not in microglia</article-title><source><italic>Cytokine</italic></source><year>1997</year><volume>9</volume><issue>10</issue><fpage>759</fpage><lpage>762</lpage><pub-id pub-id-type="other">2-s2.0-0031258670</pub-id><pub-id pub-id-type="pmid">9344508</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dewitt</surname><given-names>DA</given-names></name><name><surname>Perry</surname><given-names>G</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Doller</surname><given-names>C</given-names></name><name><surname>Silver</surname><given-names>J</given-names></name></person-group><article-title>Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer&#x02019;s disease</article-title><source><italic>Experimental Neurology</italic></source><year>1998</year><volume>149</volume><issue>2</issue><fpage>329</fpage><lpage>340</lpage><pub-id pub-id-type="other">2-s2.0-18144453796</pub-id><pub-id pub-id-type="pmid">9500964</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frautschy</surname><given-names>SA</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Irrizarry</surname><given-names>M</given-names></name><etal/></person-group><article-title>Microglial response to amyloid plaques in APPsw transgenic mice</article-title><source><italic>American Journal of Pathology</italic></source><year>1998</year><volume>152</volume><issue>1</issue><fpage>307</fpage><lpage>317</lpage><pub-id pub-id-type="other">2-s2.0-0031974406</pub-id><pub-id pub-id-type="pmid">9422548</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Hong</surname><given-names>JS</given-names></name></person-group><article-title>Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention</article-title><source><italic>Journal of Pharmacology and Experimental Therapeutics</italic></source><year>2003</year><volume>304</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="other">2-s2.0-0037215645</pub-id><pub-id pub-id-type="pmid">12490568</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease</article-title><source><italic>The Journal of Biological Chemistry</italic></source><year>2011</year><volume>286</volume><fpage>32713</fpage><lpage>32722</lpage><pub-id pub-id-type="pmid">21771791</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YJ</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><name><surname>Nam</surname><given-names>SY</given-names></name><name><surname>Oh</surname><given-names>KW</given-names></name><name><surname>Hong</surname><given-names>JT</given-names></name></person-group><article-title>Inflammation and Alzheimer&#x02019;s disease</article-title><source><italic>Archives of Pharmacal Research</italic></source><year>2010</year><volume>33</volume><issue>10</issue><fpage>1539</fpage><lpage>1556</lpage><pub-id pub-id-type="other">2-s2.0-78449234130</pub-id><pub-id pub-id-type="pmid">21052932</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>TT</given-names></name></person-group><article-title>Neurogenesis in mouse models of Alzheimer&#x02019;s disease</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2010</year><volume>1802</volume><issue>10</issue><fpage>872</fpage><lpage>880</lpage><pub-id pub-id-type="other">2-s2.0-77956064613</pub-id><pub-id pub-id-type="pmid">20056145</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez</surname><given-names>F</given-names></name><name><surname>Barreda</surname><given-names>EGD</given-names></name><name><surname>Fuster-Matanzo</surname><given-names>A</given-names></name><name><surname>Go&#x000f1;i-Oliver</surname><given-names>P</given-names></name><name><surname>Lucas</surname><given-names>JJ</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name></person-group><article-title>The role of GSK3 in Alzheimer disease</article-title><source><italic>Brain Research Bulletin</italic></source><year>2009</year><volume>80</volume><issue>4-5</issue><fpage>248</fpage><lpage>250</lpage><pub-id pub-id-type="other">2-s2.0-70349420866</pub-id><pub-id pub-id-type="pmid">19477245</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirerol-Piquer</surname><given-names>M</given-names></name><name><surname>Gomez-Ramos</surname><given-names>P</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>F</given-names></name><etal/></person-group><article-title>GSK3<italic>&#x003b2;</italic> overexpression induces neuronal death and a depletion of the neurogenic niches in the dentate gyrus</article-title><source><italic>Hippocampus</italic></source><year>2011</year><volume>21</volume><issue>8</issue><fpage>910</fpage><lpage>922</lpage><pub-id pub-id-type="other">2-s2.0-79960622123</pub-id><pub-id pub-id-type="pmid">20575007</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuster-Matanzo</surname><given-names>A</given-names></name><name><surname>Llorens-Martin</surname><given-names>M</given-names></name><name><surname>Sirerol-Piquer</surname><given-names>MS</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>JM</given-names></name><name><surname>Avila</surname><given-names>J</given-names></name><name><surname>Hernandez</surname><given-names>F</given-names></name></person-group><article-title>Dual effects of increased glycogen synthase kinase-3beta activity on adult neurogenesis</article-title><source><italic>Human Molecular Genetics</italic></source><year>2013</year></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llorens-Marti'n</surname><given-names>M</given-names></name><name><surname>Fuster-Matanzo</surname><given-names>A</given-names></name><name><surname>Teixeira</surname><given-names>CM</given-names></name><etal/></person-group><article-title>GSK-3beta overexpression causes reversible alterations on postsynaptic densities and dendritic morphology of hippocampal granule neurons in vivo</article-title><source><italic>Molecular Psychiatry</italic></source><year>2013</year></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>Z</given-names></name><name><surname>Esiri</surname><given-names>MM</given-names></name><name><surname>Smith</surname><given-names>AD</given-names></name></person-group><article-title>Expression of cell division markers in the hippocampus in Alzheimer&#x02019;s disease and other nenrodegenerative conditions</article-title><source><italic>Acta Neuropathologica</italic></source><year>1997</year><volume>93</volume><issue>3</issue><fpage>294</fpage><lpage>300</lpage><pub-id pub-id-type="other">2-s2.0-0031043049</pub-id><pub-id pub-id-type="pmid">9083562</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>K</given-names></name><name><surname>Peel</surname><given-names>AL</given-names></name><name><surname>Mao</surname><given-names>XO</given-names></name><etal/></person-group><article-title>Increased hippocampal neurogenesis in Alzheimer&#x02019;s disease</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2004</year><volume>101</volume><issue>1</issue><fpage>343</fpage><lpage>347</lpage><pub-id pub-id-type="other">2-s2.0-0346458659</pub-id><pub-id pub-id-type="pmid">14660786</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boekhoorn</surname><given-names>K</given-names></name><name><surname>Joels</surname><given-names>M</given-names></name><name><surname>Lucassen</surname><given-names>PJ</given-names></name></person-group><article-title>Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus</article-title><source><italic>Neurobiology of Disease</italic></source><year>2006</year><volume>24</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-33748790666</pub-id><pub-id pub-id-type="pmid">16814555</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Praag</surname><given-names>H</given-names></name><name><surname>Kempermann</surname><given-names>G</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Neural Consequences of environmental enrichment</article-title><source><italic>Nature Reviews Neuroscience</italic></source><year>2000</year><volume>1</volume><issue>3</issue><fpage>191</fpage><lpage>198</lpage><pub-id pub-id-type="other">2-s2.0-0034576650</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shors</surname><given-names>TJ</given-names></name><name><surname>Miesegaes</surname><given-names>G</given-names></name><name><surname>Beylin</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Rydel</surname><given-names>T</given-names></name><name><surname>Gould</surname><given-names>E</given-names></name></person-group><article-title>Neurogenesis in the adult is involved in the formation of trace memories</article-title><source><italic>Nature</italic></source><year>2001</year><volume>410</volume><issue>6826</issue><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="other">2-s2.0-0035868717</pub-id><pub-id pub-id-type="pmid">11268214</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aimone</surname><given-names>JB</given-names></name><name><surname>Wiles</surname><given-names>J</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name></person-group><article-title>Potential role for adult neurogenesis in the encoding of time in new memories</article-title><source><italic>Nature Neuroscience</italic></source><year>2006</year><volume>9</volume><issue>6</issue><fpage>723</fpage><lpage>727</lpage><pub-id pub-id-type="other">2-s2.0-33745698913</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Boekhoorn</surname><given-names>K</given-names></name><name><surname>Van Dam</surname><given-names>AM</given-names></name><name><surname>Lucassen</surname><given-names>PJ</given-names></name></person-group><article-title>Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?</article-title><source><italic>Genes, Brain and Behavior</italic></source><year>2008</year><volume>7</volume><issue>1, supplement</issue><fpage>28</fpage><lpage>42</lpage><pub-id pub-id-type="other">2-s2.0-37749053530</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoozemans</surname><given-names>JJM</given-names></name><name><surname>Veerhuis</surname><given-names>R</given-names></name><name><surname>Rozemuller</surname><given-names>AJM</given-names></name><name><surname>Eikelenboom</surname><given-names>P</given-names></name></person-group><article-title>Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer&#x02019;s disease</article-title><source><italic>Current Drug Targets</italic></source><year>2003</year><volume>4</volume><issue>6</issue><fpage>461</fpage><lpage>468</lpage><pub-id pub-id-type="other">2-s2.0-0038268656</pub-id><pub-id pub-id-type="pmid">12866660</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etminan</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>S</given-names></name><name><surname>Samii</surname><given-names>A</given-names></name></person-group><article-title>Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer&#x02019;s disease: systematic review and meta-analysis of observational studies</article-title><source><italic>British Medical Journal</italic></source><year>2003</year><volume>327</volume><issue>7407</issue><fpage>128</fpage><lpage>131</lpage><pub-id pub-id-type="other">2-s2.0-0038375640</pub-id><pub-id pub-id-type="pmid">12869452</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasinetti</surname><given-names>GM</given-names></name></person-group><article-title>From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer&#x02019;s disease: the role of NSAIDs and cyclooxygenase in <italic>&#x003b2;</italic>-amyloidosis and clinical dementia</article-title><source><italic>Journal of Alzheimer&#x02019;s Disease</italic></source><year>2002</year><volume>4</volume><issue>5</issue><fpage>435</fpage><lpage>445</lpage><pub-id pub-id-type="other">2-s2.0-0036812560</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aisen</surname><given-names>PS</given-names></name></person-group><article-title>The potential of anti-inflammatory drugs for the treatment of Alzheimer&#x02019;s disease</article-title><source><italic>Lancet Neurology</italic></source><year>2002</year><volume>1</volume><issue>5</issue><fpage>279</fpage><lpage>284</lpage><pub-id pub-id-type="other">2-s2.0-0141453824</pub-id><pub-id pub-id-type="pmid">12849425</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aisen</surname><given-names>PS</given-names></name><name><surname>Schafer</surname><given-names>KA</given-names></name><name><surname>Grundman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of rofecoxib or naproxen versus placebo on Alzheimer disease progression: a randomized controlled trial</article-title><source><italic>Journal of the American Medical Association</italic></source><year>2003</year><volume>289</volume><issue>21</issue><fpage>2819</fpage><lpage>2826</lpage><pub-id pub-id-type="other">2-s2.0-0037638809</pub-id><pub-id pub-id-type="pmid">12783912</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname><given-names>IRA</given-names></name></person-group><article-title>Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated inflammation</article-title><source><italic>Neurobiology of Aging</italic></source><year>2001</year><volume>22</volume><issue>6</issue><fpage>819</fpage><lpage>822</lpage><pub-id pub-id-type="other">2-s2.0-0035696167</pub-id><pub-id pub-id-type="pmid">11754988</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aisen</surname><given-names>PS</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name><name><surname>Berg</surname><given-names>JD</given-names></name><etal/></person-group><article-title>A randomized controlled trial of prednisone in Alzheimer&#x02019;s disease</article-title><source><italic>Neurology</italic></source><year>2000</year><volume>54</volume><issue>3</issue><fpage>588</fpage><lpage>593</lpage><pub-id pub-id-type="other">2-s2.0-0034620538</pub-id><pub-id pub-id-type="pmid">10680787</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schenk</surname><given-names>D</given-names></name><name><surname>Barbour</surname><given-names>R</given-names></name><name><surname>Dunn</surname><given-names>W</given-names></name><etal/></person-group><article-title>Immunization with amyloid-<italic>&#x003b2;</italic> attenuates Alzheimer disease-like pathology in the PDAPP mouse</article-title><source><italic>Nature</italic></source><year>1999</year><volume>400</volume><issue>6740</issue><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="other">2-s2.0-0033536163</pub-id><pub-id pub-id-type="pmid">10408445</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oddo</surname><given-names>S</given-names></name><name><surname>Vasilevko</surname><given-names>V</given-names></name><name><surname>Caccamo</surname><given-names>A</given-names></name><name><surname>Kitazawa</surname><given-names>M</given-names></name><name><surname>Cribbs</surname><given-names>DH</given-names></name><name><surname>LaFerla</surname><given-names>FM</given-names></name></person-group><article-title>Reduction of soluble A<italic>&#x003b2;</italic> and tau, but not soluble A<italic>&#x003b2;</italic> alone, ameliorates cognitive decline in transgenic mice with plaques and tangles</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2006</year><volume>281</volume><issue>51</issue><fpage>39413</fpage><lpage>39423</lpage><pub-id pub-id-type="other">2-s2.0-33846015514</pub-id><pub-id pub-id-type="pmid">17056594</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>D</given-names></name></person-group><article-title>Immunotherapy for Alzheimer&#x02019;s disease</article-title><source><italic>Journal of Internal Medicine</italic></source><year>2011</year><volume>269</volume><issue>1</issue><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="other">2-s2.0-78650210590</pub-id><pub-id pub-id-type="pmid">21158978</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemere</surname><given-names>CA</given-names></name><name><surname>Beierschmitt</surname><given-names>A</given-names></name><name><surname>Iglesias</surname><given-names>M</given-names></name><etal/></person-group><article-title>Alzheimer&#x02019;s disease A<italic>&#x003b2;</italic> vaccine reduces central nervous system A<italic>&#x003b2;</italic> levels in a non-human primate, the Caribbean vervet</article-title><source><italic>American Journal of Pathology</italic></source><year>2004</year><volume>165</volume><issue>1</issue><fpage>283</fpage><lpage>297</lpage><pub-id pub-id-type="other">2-s2.0-3042692322</pub-id><pub-id pub-id-type="pmid">15215183</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orgogozo</surname><given-names>JM</given-names></name><name><surname>Gilman</surname><given-names>S</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Subacute meningoencephalitis in a subset of patients with AD after A<italic>&#x003b2;</italic>42 immunization</article-title><source><italic>Neurology</italic></source><year>2003</year><volume>61</volume><issue>1</issue><fpage>46</fpage><lpage>54</lpage><pub-id pub-id-type="other">2-s2.0-10744230547</pub-id><pub-id pub-id-type="pmid">12847155</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hock</surname><given-names>C</given-names></name><name><surname>Konietzko</surname><given-names>U</given-names></name><name><surname>Streffer</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Antibodies against <italic>&#x003b2;</italic>-amyloid slow cognitive decline in Alzheimer&#x02019;s disease</article-title><source><italic>Neuron</italic></source><year>2003</year><volume>38</volume><issue>4</issue><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="other">2-s2.0-0038100154</pub-id><pub-id pub-id-type="pmid">12765607</pub-id></element-citation></ref><ref id="B106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenmann</surname><given-names>H</given-names></name><name><surname>Meiner</surname><given-names>Z</given-names></name><name><surname>Geylis</surname><given-names>V</given-names></name><name><surname>Abramsky</surname><given-names>O</given-names></name><name><surname>Steinitz</surname><given-names>M</given-names></name></person-group><article-title>Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer&#x02019;s disease and healthy subjects</article-title><source><italic>Neuroscience Letters</italic></source><year>2006</year><volume>410</volume><issue>2</issue><fpage>90</fpage><lpage>93</lpage><pub-id pub-id-type="other">2-s2.0-33750681275</pub-id><pub-id pub-id-type="pmid">17095156</pub-id></element-citation></ref><ref id="B107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotz</surname><given-names>J</given-names></name><name><surname>Ittner</surname><given-names>A</given-names></name><name><surname>Ittner</surname><given-names>LM</given-names></name></person-group><article-title>Tau-targeted treatment strategies in Alzheimer's disease</article-title><source><italic>British Journal of Pharmacology</italic></source><year>2012</year><volume>165</volume><fpage>1246</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">22044248</pub-id></element-citation></ref><ref id="B108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>M</given-names></name><name><surname>Maeda</surname><given-names>S</given-names></name><name><surname>Vossel</surname><given-names>K</given-names></name><name><surname>Mucke</surname><given-names>L</given-names></name></person-group><article-title>The Many Faces of Tau</article-title><source><italic>Neuron</italic></source><year>2011</year><volume>70</volume><issue>3</issue><fpage>410</fpage><lpage>426</lpage><pub-id pub-id-type="other">2-s2.0-79955670132</pub-id><pub-id pub-id-type="pmid">21555069</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberson</surname><given-names>ED</given-names></name><name><surname>Scearce-Levie</surname><given-names>K</given-names></name><name><surname>Palop</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Reducing endogenous tau ameliorates amyloid <italic>&#x003b2;</italic>-induced deficits in an Alzheimer&#x02019;s disease mouse model</article-title><source><italic>Science</italic></source><year>2007</year><volume>316</volume><issue>5825</issue><fpage>750</fpage><lpage>754</lpage><pub-id pub-id-type="other">2-s2.0-34248181511</pub-id><pub-id pub-id-type="pmid">17478722</pub-id></element-citation></ref><ref id="B110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ittner</surname><given-names>LM</given-names></name><name><surname>G&#x000f6;tz</surname><given-names>J</given-names></name></person-group><article-title>Amyloid-<italic>&#x003b2;</italic> and tau&#x02014;a toxic pas de deux in Alzheimer&#x02019;s disease</article-title><source><italic>Nature Reviews Neuroscience</italic></source><year>2011</year><volume>12</volume><issue>2</issue><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="other">2-s2.0-78751644048</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Effects of different cytokines on neurogenesis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Cytokine</th><th align="left" rowspan="1" colspan="1">Effects on neurogenesis</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">IL-1<italic>&#x003b1;</italic></td><td align="left" rowspan="1" colspan="1">Increased astrocyte lineage</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B37">41</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">IL-1<italic>&#x003b2;</italic></td><td align="left" rowspan="1" colspan="1">Stimulation of NPCs proliferation and differentiation<break/>Decreased proliferation, survival, and neuronal differentiation<break/>Increased astrocyte differentiation</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B38">42</xref>]<break/>[<xref ref-type="bibr" rid="B39">43</xref>]<break/>[<xref ref-type="bibr" rid="B40">44</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">IL-4</td><td align="left" rowspan="1" colspan="1">Increased oligodendrogenesis</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B41">45</xref>] </td></tr><tr><td align="left" rowspan="3" colspan="1">IL-6</td><td align="left" rowspan="1" colspan="1">Decreased proliferation, survival, and neuronal differentiation</td><td align="center" rowspan="3" colspan="1">
[<xref ref-type="bibr" rid="B42">46</xref>]<break/>[<xref ref-type="bibr" rid="B43">47</xref>] <break/> [<xref ref-type="bibr" rid="B44">48</xref>]<break/>[<xref ref-type="bibr" rid="B45">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">Differentiation of NSC to neuronal lineages</td></tr><tr><td align="left" rowspan="1" colspan="1">Increased neurogenesis </td></tr><tr><td align="left" rowspan="1" colspan="1">IL-10</td><td align="left" rowspan="1" colspan="1">Increased proliferation</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B46">50</xref>]<break/>[<xref ref-type="bibr" rid="B47">51</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">IL-18</td><td align="left" rowspan="1" colspan="1">Decreased survival<break/>Increased neuronal differentiation</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B48">52</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">IFN-<italic>&#x003b3;</italic></td><td align="left" rowspan="1" colspan="1">Decreased proliferation and survival of multipotent progenitors<break/>Promotion of differentiation and neurite outgrowth</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B49">53</xref>]<break/>[<xref ref-type="bibr" rid="B50">54</xref>]<break/>[<xref ref-type="bibr" rid="B51">55</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">CCL11 (eotaxin-1)</td><td align="left" rowspan="1" colspan="1">Decreased Sox-2 progenitors, proliferation, and neuronal differentiation</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B28">28</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">CX3CL1 (fractalkine)</td><td align="left" rowspan="1" colspan="1">Decreased neurogenesis</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B52">56</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">GM-CSF</td><td align="left" rowspan="1" colspan="1">Stimulation of NPCs differentiation</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B53">57</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1">G-CSF</td><td align="left" rowspan="1" colspan="1">Promotes NPCs differentiation</td><td align="center" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="B27">27</xref>] </td></tr><tr><td align="left" rowspan="1" colspan="1">TGF-<italic>&#x003b2;</italic></td><td align="left" rowspan="1" colspan="1">Decreased proliferation<break/>Increased survival and neural differentiation</td><td align="center" rowspan="1" colspan="1"> [<xref ref-type="bibr" rid="B54">58</xref>]<break/>[<xref ref-type="bibr" rid="B55">59</xref>] <break/>[<xref ref-type="bibr" rid="B56">60</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>